In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Helix, Illumina Goes Consumer – Again

Executive Summary

After failing to tap into the consumer market six years ago with a health-information-oriented Personal Genomics Service, Illumina is taking a new tack in trying to leverage the value of its industry-leading gene sequencing platform – in this case setting its sights well beyond medicine and even wellness. Its new $100 million venture, Helix, also backed by two large investors, intends to become a massive “app store,” with partners creating content derived from consumers’ genomic information.

Advertisement

Related Content

The A-List: The Trend-Shaping Series A Financings Of 2015
Device/Diagnostics Quarterly Deal Statistics, Q3 2015
Illumina Goes Consumer
Championing the Consumer: Millennium's New Vitivity Health Information Business

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004425

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel